We are live on ! Find out more
BCA

Benchmark Capital Advisors Portfolio holdings

AUM $101M
1-Year Est. Return 0.8%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
-0.8%
3 Year Est. Return
+29.53%
5 Year Est. Return
+43.22%
10 Year Est. Return
AUM
$128M
AUM Growth
-$605K
Cap. Flow
-$4.31M
Cap. Flow %
-3.36%
Top 10 Hldgs %
30.46%
Holding
151
New
9
Increased
24
Reduced
61
Closed
14

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$1.23M
2
MRK icon
Merck
MRK
+$1.04M
3
GM icon
General Motors
GM
+$1.02M
4
REM icon
iShares Mortgage Real Estate ETF
REM
+$990K
5
ABBV icon
AbbVie
ABBV
+$982K

Sector Composition

Rank Sector Weight
1 Miscellaneous 20.53%
2 Healthcare 15.93%
3 Real Estate 15.05%
4 Financials 12.27%
5 Technology 12.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OHI icon
51
Omega Healthcare
OHI
$14B
$647K 0.5%
23,475
-1,500
-6% -$43.3K
DEM icon
52
WisdomTree Emerging Markets High Dividend Fund
DEM
$4.14B
$644K 0.5%
14,199
+400
+3% +$17.5K
GOOG icon
53
Alphabet (Google) Class C
GOOG
$4.13T
$637K 0.5%
12,180
+180
+2% +$9.16K
GALT icon
54
Galectin Therapeutics
GALT
$418M
$619K 0.48%
185,200
-9,000
-5% -$22.8K
DOC icon
55
Healthpeak Properties
DOC
$14.6B
$613K 0.48%
23,500
-5,250
-18% -$139K
AMGN icon
56
Amgen
AMGN
$236B
$609K 0.48%
3,500
META icon
57
Meta Platforms (Facebook)
META
$1.45T
$609K 0.48%
3,452
-98
-3% -$17.3K
JNJ icon
58
Johnson & Johnson
JNJ
$640B
$575K 0.45%
+4,113
New +$573K
MET.PRA icon
59
MetLife Inc Floating Rate Series A
MET.PRA
$507M
$574K 0.45%
23,100
SAFE
60
Safehold
SAFE
$1.09B
$571K 0.45%
10,385
-103
-1% -$5.81K
KW
61
DELISTED
Kennedy-Wilson Holdings
KW
$564K 0.44%
32,500
JCI icon
62
Johnson Controls International
JCI
$86.1B
$549K 0.43%
14,400
-1,200
-8% -$46.9K
CEMI
63
DELISTED
Chembio diagnostics, Inc.
CEMI
$545K 0.43%
66,417
+33,517
+102% +$227K
CTSH icon
64
Cognizant
CTSH
$28.7B
$536K 0.42%
7,550
-100
-1% -$7.31K
COP icon
65
ConocoPhillips
COP
$156B
$530K 0.41%
9,650
-1,400
-13% -$72K
AGIG
66
Abundia Global Impact Group
AGIG
$42.8M
$514K 0.4%
12,472
-84
-0.7% -$4.12K
RGLD icon
67
Royal Gold
RGLD
$22.8B
$509K 0.4%
6,200
ROIC
68
DELISTED
Retail Opportunity Investments Corp.
ROIC
$479K 0.37%
24,000
MS.PRA icon
69
Morgan Stanley Series A Preferred Stock
MS.PRA
$756M
$466K 0.36%
20,605
RDI icon
70
Reading International Class A
RDI
$48.1M
$461K 0.36%
27,600
BRK.B icon
71
Berkshire Hathaway Class B
BRK.B
$1.08T
$456K 0.36%
2,300
GM.WS.B
72
CALL
DELISTED
General Motors Company
GM.WS.B
$453K 0.35%
19,346
-1,500
-7% -$38.3K
SNY icon
73
Sanofi
SNY
$107B
$451K 0.35%
10,500
-1,100
-9% -$50.7K
CCEC
74
Capital Clean Energy Carriers
CCEC
$1.37B
$444K 0.35%
18,897
-929
-5% -$21.8K
ALLY icon
75
Ally Financial
ALLY
$13B
$437K 0.34%
15,000

Similar funds

Benchmark Capital Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Benchmark Capital Advisors held 151 positions worth $128M, down 0.47% from $129M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Benchmark Capital Advisors withdrew a net $4.31M in Q4 2017, closing 14 positions and reducing 61 holdings. Its most notable exit was Procter & Gamble, an estimated $1.23M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Real Estate.

Against the trend, Benchmark Capital Advisors opened a new position in Intel worth $1.02M.

  • Benchmark Capital Advisors's largest Q4 2017 buy was Intel: 22,000 shares worth $1.02M.
  • Benchmark Capital Advisors added most to Walt Disney in Q4 2017, an estimated $627K increase.
  • Benchmark Capital Advisors's biggest Q4 2017 reduction was General Motors, cutting an estimated $1.02M.
  • Benchmark Capital Advisors fully exited Procter & Gamble in Q4 2017, selling an estimated $1.23M.
  • Benchmark Capital Advisors's ten largest holdings make up 30% of its $128M portfolio in Q4 2017.
  • Benchmark Capital Advisors opened 9 new positions and closed 14 in Q4 2017.
  • Benchmark Capital Advisors's portfolio value fell 0.47% quarter-over-quarter to $128M.

Based on Benchmark Capital Advisors's 13F filing for Q4 2017, filed 7 Feb 2018.